Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins

This publication has 17 references indexed in Scilit:

• Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
  New England Journal of Medicine, 2004
• Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
  Science, 2004
• Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia
  Circulation, 2003
• Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats
  British Journal of Pharmacology, 2003
• Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia
  The American Journal of Cardiology, 2003
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
  Circulation, 2002
• Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia
  The American Journal of Cardiology, 2002
• Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans
  Circulation, 2002
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function
  British Journal of Pharmacology, 2001